1-7 of 7
Steven D. Gore, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Statistically Significant Differences In Toxicities Between L- and PEG Asparaginase In Adult Patients with Acute Lymphoblastic Leukemia

Gustavo A. Rivero, MD, Kayleen Bailey, Amanda Blackford, Amy Seung, Steven D. Gore, M.D., Judith E. Karp, MD, Hetty E. Carraway, MD, MBA
Journal: Blood
Blood (2010) 116 (21): 2121.
https://doi.org/10.1182/blood.V116.21.2121.2121
Published: 2010
Journal Articles

Patients with FLT3/ITD AML May Benefit From Allogeneic Transplant In First Remission: Outcomes From a Consecutive Series of Patients at a Single Institution

Amy E. DeZern, MD, Anthony Sung, MD, Sharon Kim, MD, Hua-Ling Tsai, MS, Jeanne Kowalski, PhD, B. Douglas Smith, MD, Judith E. Karp, MD, Steven D. Gore, M.D., Ephraim Fuchs, MD, Michael A McDevitt, MD, PhD, Leo Luznik, MD, Richard J. Jones, MD, Mark J. Levis, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2172.
https://doi.org/10.1182/blood.V116.21.2172.2172
Published: 2010
Journal Articles

Access to Care, Race and Education Are Key Determinants of Erythropoietin Stimulating Agent (ESA) Use In Myelodysplastic Syndromes (MDS).

Amy J. Davidoff, PhD, M.S., Sheila Weiss Smith, PhD, Maria R Baer, M.D., Xuehua Ke, M.A., Jason M Bierenbaum, M.D., Franklin Hendrick, B.S., Diane L. McNally, BSPharm, M.S., Steven D. Gore, M.D.
Journal: Blood
Blood (2010) 116 (21): 3815.
https://doi.org/10.1182/blood.V116.21.3815.3815
Published: 2010
Journal Articles

A 10 Day Schedule of Azacitidine Induces More Complete Cytogenetic Remissions Than the Standard Schedule In Myelodysplasia and Acute Myeloid Leukemia with Myelodysplasia-Related Changes: Results of the E1905 US Leukemia Intergroup Study

Thomas Prebet, M.D., Ph.D., Zhuoxin Sun, PhD, Rhett Ketterling, Gary Hicks, Ph.D., C.L. Beach, PharmD, Peter L. Greenberg, MD, Elisabeth Paietta, PhD, Magdalena Czader, M.D., Ph.D., Janice Gabrilove, M.D., Harry P Erba, DM, PhD, Martin S. Tallman, MD, Steven D. Gore, M.D.
Journal: Blood
Blood (2010) 116 (21): 4013.
https://doi.org/10.1182/blood.V116.21.4013.4013
Published: 2010
Journal Articles

Outcome of Patients (pts) Treated for Myelodysplastic Syndrome (MDS) and Secondary Acute Myeloid Leukemia (s AML) After Azacitidine (AZA) Failure

Thomas Prebet, M.D., Ph.D., Steven D. Gore, M.D., Benjamin Esterni, Ph.D., Raphael Itzykson, Sylvain Thepot, C.L. Beach, PharmD, Pierre Fenaux, MD, PhD, Norbert Vey, MD
Journal: Blood
Blood (2010) 116 (21): 443.
https://doi.org/10.1182/blood.V116.21.443.443
Published: 2010
Journal Articles

Prolonged Administration of Azacitidine with or without Entinostat Increases Rate of Hematologic Normalization for Myelodysplastic Syndrome and Acute Myeloid Leukemia with Myelodysplasia-Related Changes: Results of the US Leukemia Intergroup Trial E1905

Thomas Prebet, M.D., Ph.D., Steven D. Gore, M.D., Zhuoxin Sun, PhD, Peter L. Greenberg, MD, Mark Juckett, MD, Lisa Malick, Mitchell R Smith, MD, PhD, Elisabeth Paietta, PhD, Magdalena Czader, Janice Gabrilove, M.D., Harry P Erba, DM, PhD, Martin S. Tallman, MD
Journal: Blood
Blood (2010) 116 (21): 601.
https://doi.org/10.1182/blood.V116.21.601.601
Published: 2010
Journal Articles

Characteristics and Outcome of Patients with Core Binding Factor Acute Myelogenous Leukemia Treated with Timed Sequential Chemotherapy.

Gustavo A. Rivero, MD, Kayleen Bailey, Amanda Blackford, Constance Griffin, M.D., Katharine Oteiza, Steven D. Gore, M.D., Judith E. Karp, MD, Hetty E. Carraway, MD, MBA
Journal: Blood
Blood (2010) 116 (21): 1045.
https://doi.org/10.1182/blood.V116.21.1045.1045
Published: 2010